5609-0733 Screening compound: (2E)-2-cyano-N-(3-ethoxyphenyl)-3-{1-[2-(morpholin-4-yl)-2-oxoethyl]-1H-indol-3-yl}prop-2-enamide

5609-0733 Screening compound: (2E)-2-cyano-N-(3-ethoxyphenyl)-3-{1-[2-(morpholin-4-yl)-2-oxoethyl]-1H-indol-3-yl}prop-2-enamide
5609-0733 Screening compound: (2E)-2-cyano-N-(3-ethoxyphenyl)-3-{1-[2-(morpholin-4-yl)-2-oxoethyl]-1H-indol-3-yl}prop-2-enamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 5609-0733
(2E)-2-cyano-N-(3-ethoxyphenyl)-3-{1-[2-(morpholin-4-yl)-2-oxoethyl]-1H-indol-3-yl}prop-2-enamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

5609-0733

Molecular Formula

C26H26N4O4 (C26 H26 N4 O4)

Compound Name

(2E)-2-cyano-N-(3-ethoxyphenyl)-3-{1-[2-(morpholin-4-yl)-2-oxoethyl]-1H-indol-3-yl}prop-2-enamide

IUPAC name

(2E)-2-cyano-N-(3-ethoxyphenyl)-3-{1-[2-(morpholin-4-yl)-2-oxoethyl]-1H-indol-3-yl}prop-2-enamide

SMILES

CCOc1cccc(NC(/C(/C#N)=C/c2cn(CC(N3CCOCC3)=O)c3c2cccc3)=O)c1

InChI

InChI=1S/C26H26N4O4/c1-2-34-22-7-5-6-21(15-22)28-26(32)19(16-27)14-20-17-30(24-9-4-3-8-23(20)24)18-25(31)29-10-12-33-13-11-29/h3-9,14-15,17H,2,10-13,18H2,1H3,(H,28,32)

InChI Key

ZVWWOCPIOQSPJN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD03240087

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

458.52

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.922

Distribution Coefficient, logD

2.890

Water Solubility, LogSw

-3.22

Polar Surface Area

73.543

Acid Dissociation Constant (pKa)

8.53

Base Dissociation Constant (pKb)

0.60

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.90

5609-0733 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PI3K-Targeted Library (17255 compounds)

Covalent Inhibitors Library (7986 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
Structure:
  • Cyclic compounds
  • 3D
  • Fragments

References: we are preparing a list of scientific research reports with 5609-0733 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 5609-0733?
Check Price and Availability of 5609-0733, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 5609-0733 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 5609-0733
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 5609-0733
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 5609-0733 available by request